Medicina clinica
The most recent articles from:
March 2020
-
Case Reports Observational Study
Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus.
Oral antidiabetic inhibitors of the sodium-glucose cotransporter (SGLT2i) reduce cardiovascular morbidity and mortality in DM2. The increase in arterial stiffness can participate in this morbidity and mortality. The aim of this study was to analyse the effect of the administration of dapagliflozin on arterial stiffness. ⋯ Dapagliflozin, in subjects with DM2, produces a medium to long-term decrease in arterial stiffness.